Cervical cancer screening saves lives. Secondary prevention in cervical cancer screening
relies on the results of primary cytology and/or HPV testing. However, primary screening with …

Cervical cancer screening has enabled a decrease in the incidence and mortality of cervical
cancer. Various screening modalities have been studied to date. In many countries …

BACKGROUND Testing for the presence of the human papillomavirus (HPV) is widely
accepted for triaging Papanicolaou cytology results categorized as atypical squamous cells …

Background Women with atypical squamous cells of undetermined significance (ASC‐US)
can be triaged accurately with a high‐risk human papillomavirus (hrHPV) test to identify …

The aim of this study was to evaluate the clinical utility of p16/Ki-67 dual staining, for the
identification of CIN in high-risk HPV-positive women from a non-responder screening …

The objective of this study was to determine the diagnostic accuracy of pap smear and
colposcopy in detecting the premalignant and malignant lesion of the cervix. In this cross …

Context.—In 2014, the College of American Pathologists developed an evidence-based
guideline to address analytic validation of immunohistochemical assays. Fourteen …

BACKGROUND: The Papanicolaou (Pap) test is one screening strategy used to prevent
cervical cancer in developed countries. The p16/Ki-67 immunocytochemistry is a triage test …

Globally, cervical cancer (CC) screening is moving from cytology-based to HPV screening or
a combination of both (co-testing). Most HPV-positive women clear the virus and do not …

Introduction Cervical cancer is the most common cancer in India. Screening for cervical
cancer helps in marked reduction of invasive cervical cancers. The low sensitivity of …